Search for: "New Pharma, Inc." Results 81 - 100 of 990
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2008, 8:52 pm
On Feb. 1, FDA posted a new comprehensive list of FDA Guidance Documents, which could come in handy for FDA-regulated companies. [read post]
24 Jul 2011, 9:16 pm by Patent Docs
Nycomed U.S., Inc. 1:11-cv-04962; filed July 19, 2011 in the Southern District of New York Medicis Pharmaceutical Corp. v. [read post]
23 Jun 2010, 10:28 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2010, 2:33 pm
Announcements like Merck's recent SEC filing that it is now the subject an FCPA investigation involving other Pharma companies should become common, as corruption will now be increasingly exposed in a new wave of SEC Whistleblower cases. [read post]
8 Jan 2012, 9:05 pm by Patent Docs
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
11 Jan 2017, 2:30 pm by Kun Zhao, Esq.
(“Dishman”), won a significant victory on December 29, 2016, when the Appellate Division of the New Jersey Superior Court held that Dishman could not be sued in state court even though one of its subsidiaries, Dishman USA, Inc., is located in New Jersey. [read post]
5 May 2010, 4:46 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Feb 2010, 8:35 pm by Patent Docs
Lupin, Ltd. et al. 2:10-cv-00603; filed February 3, 2010 in the District Court of New Jersey • Plaintiff: Teva Women's Health, Inc. [read post]
18 Sep 2011, 9:55 pm by Patent Docs
Accord Healthcare, Inc. 1:11-cv-06360; filed September 12, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc. [read post]
26 Sep 2010, 8:41 pm by Patent Docs
Par Pharmaceutical Companies, Inc. et al. 1:10-cv-07310; filed September 22, 2010 in the Southern District of New York • Plaintiff: Biovail Laboratories International SRL • Defendants: Par Pharmaceutical Companies, Inc.; Par Pharmaceuticals, Inc. [read post]
27 Oct 2013, 9:55 pm by Patent Docs
Reddy's Laboratories Inc. et al. 3:13-cv-06157; filed October 23, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; KBI-E Inc.; Pozen, Inc.; Astrazeneca LP • Defendants: Dr. [read post]
4 Aug 2010, 12:21 am by Kelly
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
20 Mar 2011, 9:55 pm by Patent Docs
Nycomed US, Inc. et al. 2:11-cv-01280; filed March 17, 2011 in the Eastern District of New York • Plaintiff: Glycobiosciences, Inc. [read post]
12 Mar 2019, 10:54 am by Patrick A. Malone
DaVita Inc. and Fresenius Medical Care AG run more than 5,000 U.S. dialysis clinics and control around 70 percent of the market, Reuters news service reported in a story describing how Alex Azar, the powerful head of the federal Health and Human Services department, wants “a new payment approach for treating kidney disease that favors lower cost care at home and transplants. [read post]
8 Apr 2010, 7:55 pm by Josh Myers
  The Federal Food and Drug Administration has issued a mandate requiring the makers of Reglan (Scharz Pharma, Inc) to include a black box warning on the labels of Reglan warning of the probability that it may cause Tardive Dyskinesia. [read post]
28 Sep 2008, 8:48 pm
Pharmaceutical Associates, Inc.3:08-cv-04718; filed September 19. 2008 in the District Court of New Jersey Infringement of U.S. [read post]
30 Oct 2009, 3:11 pm
Schwarz Pharma, Inc., -- F.3d --, 2009 WL 3460808 (7th Cir.) [read post]
15 Feb 2011, 5:26 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]